Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Xenon Pharmaceuticals Q2 EPS $(0.55) Misses $(0.48) Estimate

Xenon Pharmaceuticals (NASDAQ:XENE) reported quarterly losses of $(0.55) per share which missed the analyst consensus estimate of $(0.48) by 14.58 percent. This is a 7.84 percent decrease over losses of $(0.51) per share
byBenzinga Newsdesk
August 9, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Xenon Pharmaceuticals (NASDAQ:XENE) reported quarterly losses of $(0.55) per share which missed the analyst consensus estimate of $(0.48) by 14.58 percent. This is a 7.84 percent decrease over losses of $(0.51) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

‘Avatar: The Way Of Water’ Box Office Preview: How Much Record-Breaking Movie’s Sequel Could Gross And 5 Stocks To Watch

By Chris Katje
December 15, 4:31 PM
One of the most highly anticipated movies of 2022 is set to be released Dec. 16, just in time for the holidays and the end-of-year box office push. Here’s a look at early predictions for how much “Avatar: The Way Of Water” could gross and the stocks it could help.

AMC